Publications by authors named "E Hermosilla"
Background: In Catalonia, infants <6 months old were eligible to receive nirsevimab, a novel monoclonal antibody against respiratory syncytial virus (RSV). We aimed to analyze nirsevimab's effectiveness in hospital-related outcomes of the seasonal cohort (born during the RSV epidemic from October to January 2024) and compared them with the catch-up cohort (born from April to September 2023).
Methods: Retrospective cohort study of all infants born between October 1, 2023, and January 21, 2024, according to their immunization with nirsevimab (immunized and nonimmunized).
Background: The relative efficacy of information provision versus financial incentives in improving primary care quality remains a critical, unresolved question. We investigated these two strategies in Catalonia's public primary care system from 2010 to 2019: an innovative online platform providing real-time quality indicator information and targeted economic incentives for achieving indicator goals.
Methods: We conducted a comprehensive interrupted time series regression analysis on data from 272 primary care practices (5,628,080 patients).
Article Synopsis
- Respiratory syncytial virus (RSV) significantly impacts infants, leading to numerous cases of bronchiolitis and deaths yearly, especially among those under 6 months old.
- In Catalonia, a new monoclonal antibody called nirsevimab has been available since October 2023 for infants in their first RSV season.
- Preliminary data show a reduction in RSV infection rates and bronchiolitis incidence in the 2023/2024 season compared to previous years, coinciding with high coverage of nirsevimab administration.
Article Synopsis
- * It analyzed data from over 26,500 infants between October 2023 and January 2024, comparing outcomes between those who received nirsevimab and those who did not.
- * Results showed significant reductions in hospital and ICU admissions due to RSV bronchiolitis, with 87.6% and 90.1% lower rates, respectively, indicating nirsevimab's potential impact on public health initiatives targeting RSV.
Chlorpyrifos (CP) is a globally used pesticide with acute toxicity. This work studied the photocatalytic degradation of CP using TiO, ZnO nanoparticles, and nanocomposites of TiO and ZnO supported on SPIONs (SPION@SiO@TiO and SPION@SiO@ZnO). The nanocomposites were synthesized by multi-step incipient wetness impregnation.
View Article and Find Full Text PDF